U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07478107) titled 'Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid' on March 12.
Brief Summary: In gastrointestinal malignancies peritoneal diffusion represent a severe adverse event. Current methodoly including cytology of peritoneal fluid appears insufficient. It's crucial to individuate new technology.
Study Start Date: July 01, 2024
Study Type: OBSERVATIONAL
Condition:
Peritoneal Diffusion
Recruitment Status: COMPLETED
Sponsor: University of Campania Luigi Vanvitelli
Information provided by (Responsible Party): Gennaro Galizia, University of Campania Luigi Vanvitelli
Disclaimer: Curated by HT Syndication....